Article

Relationship Between Alcohol Consumption and Cancer Discovered

Even low-to-moderate drinking can increase cancer risk.

Findings from a recent study suggests a dose-response relationship between alcohol consumption and an increased risk of developing cancer.

In meta-analysis published by Addiction, researchers used data from the World Cancer Research Fund, American Institute for Cancer Research, the International Agency for Research on Cancer, and the Global Burden of Disease Alcohol Group.

The researchers said their study shows a casual association between alcohol consumption and cancer occurring in 7 sites: oropharynx, larynx, esophagus, liver, colon, rectum, and breast. Researchers found that when alcohol consumption decreased, the cancer risk was also decreased.

They also discovered that evidence moderate drinking can protect against cardiovascular disease is not sufficient. In 2012, 5.8% of cancer deaths were due to alcohol consumption, according to the study.

Although researchers caution that heavy drinking can cause a large increase, they also state that low-to-moderate drinking increases the risk as well.

Related Videos
Anthony Perissinotti, PharmD, BCOP, discusses unmet needs and trends in managing chronic lymphocytic leukemia (CLL), with an emphasis on the pivotal role pharmacists play in supporting medication adherence and treatment decisions.
Image Credit: © alenamozhjer - stock.adobe.com
pharmacogenetics testing, adverse drug events, personalized medicine, FDA collaboration, USP partnership, health equity, clinical decision support, laboratory challenges, study design, education, precision medicine, stakeholder perspectives, public comment, Texas Medical Center, DNA double helix
pharmacogenetics challenges, inter-organizational collaboration, dpyd genotype, NCCN guidelines, meta census platform, evidence submission, consensus statements, clinical implementation, pharmacotherapy improvement, collaborative research, pharmacist role, pharmacokinetics focus, clinical topics, genotype-guided therapy, critical thought
Image Credit: © Andrey Popov - stock.adobe.com
Image Credit: © peopleimages.com - stock.adobe.com
TRUST-I and TRUST-II Trials Show Promising Results for Taletrectinib in ROS1+ NSCLC
Image Credit: © Krakenimages.com - stock.adobe.com